Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia

Neurobiology of Aging

Volumn 33, Issue 4, 2012, Pages 791-803

  Proitsi, Petroula ^a   Lupton, Michelle K ^a   Reeves, Suzanne J ^a   Hamilton, Gillian ^b   Archer, Nicola ^a   Martin, Belinda M ^a   Iyegbe, Conrad ^a   Hollingworth, Paul ^c   Lawlor, Brian ^d   Gill, Michael ^d   Brayne, Carol ^e   Rubinsztein, David C ^f   Owen, Michael J ^c   Williams, Julie ^c   Lovestone, Simon ^a   Powell, John F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d ST JAMES S HOSPITAL   (Ireland)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alzheimer's disease (AD); BPSD; Covariates; Dopamine; Genes; Interactions; Medication; Multiple indicators multiple causes (MIMIC) model; NPI; Serotonin; SNP

Indexed keywords

DOPAMINE; SEROTONIN;

12 ITEM NEUROPSYCHIATRIC INVENTORY; ADULT; AGED; AGITATION; ALZHEIMER DISEASE; APATHY; ARTICLE; BEHAVIOR DISORDER; DAT GENE; DEMENTIA; DEPRESSION; DOPAMINERGIC SYSTEM; DRD1 GENE; DRD3 GENE; DRD4 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MODEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MULTIPLE INDICATORS MULTIPLE CAUSES MODEL; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSIS; SEROTONINERGIC SYSTEM; SERT GENE; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; BEHAVIORAL SYMPTOMS; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DEMENTIA; DNA MUTATIONAL ANALYSIS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MODELS, BIOLOGICAL; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE; RISK FACTORS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84856947687     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.06.011     Document Type: Article

References (74)

1. Agrawal A., Lynskey M.T., Madden P.A., Bucholz K.K., Heath A.C. A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 2007, 102:94-104.
2. Assal F., Alarcon M., Solomon E.C., Masterman D., Geschwind D.H., Cummings J.L. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch. Neurol 2004, 61:1249-1253.
3. Bacanu S.A., Devlin B., Chowdari K.V., DeKosky S.T., Nimgaonkar V.L., Sweet R.A. Heritability of psychosis in Alzheimer disease. Am. J. Geriatr. Psychiatry 2005, 13:624-627.
4. Benjamin J., Osher Y., Lichtenberg P., Bachner-Melman R., Gritsenko I., Kotler M., Belmaker R.H., Valsky V., Drendel M., Ebstein R.P. An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to tridimensional personality questionnaire persistence scores in normal subjects. Neuropsychobiology 2000, 41:48-53.
5. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. Ser. B 1995, 57:289-300.
6. Bertolino A., Blasi G., Latorre V., Rubino V., Rampino A., Sinibaldi L., Caforio G., Petruzzella V., Pizzuti A., Scarabino T., Nardini M., Weinberger D.R., Dallapiccola B. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J. Neurosci 2006, 26:3918-3922.
7. Bertolino A., Caforio G., Blasi G., De C.M., Latorre V., Petruzzella V., Altamura M., Nappi G., Papa S., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., Nardini M. Interaction of COMT (Val(108/158) Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am. J. Psychiatry 2004, 161:1798-1805.
8. Borroni B., Agosti C., Archetti S., Costanzi C., Bonomi S., Ghianda D., Lenzi G.L., Caimi L., Di L.M., Padovani A. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease. Neurosci. Lett 2004, 370:127-129.
9. Borroni B., Grassi M., Agosti C., Archetti S., Costanzi C., Cornali C., Caltagirone C., Caimi L., Di L.M., Padovani A. Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease. Am. J. Geriatr. Psychiatry 2006, 14:343-351.
10. Borroni B., Grassi M., Agosti C., Costanzi C., Archetti S., Franzoni S., Caltagirone C., Di L.M., Caimi L., Padovani A. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol. Aging 2006, 27:1595-1603.
11. Caldu X., Vendrell P., Bartres-Faz D., Clemente I., Bargallo N., Jurado M.A., Serra-Grabulosa J.M., Junque C. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 2007, 37:1437-1444.
12. Cervilla J.A., Rivera M., Molina E., Torres-Gonzalez F., Bellon J.A., Moreno B., de Dios L.J., Lorente J.A., de Diego-Otero Y., King M., Nazareth I., Gutierrez B. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am. J. Med. Genet. B Neuropsychiatr. Genet 2006, 141B:912-917.
13. Chen C.K., Chen S.L., Mill J., Huang Y.S., Lin S.K., Curran S., Purcell S., Sham P., Asherson P. The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol. Psychiatry 2003, 8:393-396.
14. Chung T., Martin C.S. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents. J. Consult. Clin. Psychol 2005, 73:995-1004.
15. Collier D.A., Arranz M.J., Sham P., Battersby S., Vallada H., Gill P., Aitchison K.J., Sodhi M., Li T., Roberts G.W., Smith B., Morton J., Murray R.M., Smith D., Kirov G. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 1996, 7:1675-1679.
16. Craig D., Donnelly C., Hart D., Carson R., Passmore P. Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet 2007, 144B:126-128.
17. Craig D., Hart D.J., Carson R., McIlroy S.P., Passmore A.P. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene. Neurosci. Lett 2004, 368:33-36.
18. Craig D., Hart D.J., McCool K., McIlroy S.P., Passmore A.P. Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:1327-1330.
19. Craig D., Hart D.J., Passmore A.P. Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006, 29:1003-1007.
20. Cummings J.L. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997, 48:S10-S16.
21. Dean B., Laws S.M., Hone E., Taddei K., Scarr E., Thomas E.A., Harper C., McClean C., Masters C., Lautenschlager N., Gandy S.E., Martins R.N. Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biol. Psychiatry 2003, 54:616-622.
22. Donaldson C., Tarrier N., Burns A. Determinants of carer stress in Alzheimer's disease. Int. J. Geriatr. Psychiatry 1998, 13:248-256.
23. Edenberg H.J., Reynolds J. Improved method for detecting the long and short promoter alleles of the serotonin transporter gene HTT (SLC6A4). Psychiatr. Genet 1998, 8:193-195.
24. Fan J.B., Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol. Psychiatry 2005, 10:928-938.
25. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
26. Furlong R.A., Ho L., Walsh C., Rubinsztein J.S., Jain S., Paykel E.S., Easton D.F., Rubinsztein D.C. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am. J. Med. Genet 1998, 81:58-63.
27. Gallo J.J., Anthony J.C., Muthen B.O. Age differences in the symptoms of depression: a latent trait analysis. J. Gerontol 1994, 49:251-264.
28. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofield P.R., Gordon E., Kemp A.H., Williams L.M. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol. Psychiatry 2009, 14:681-695.
29. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med 2002, 21:35-50.
30. Greenwood T.A., Alexander M., Keck P.E., McElroy S., Sadovnick A.D., Remick R.A., Kelsoe J.R. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am. J. Med. Genet 2001, 105:145-151.
31. Guo G., Roettger M.E., Shih J.C. Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum. Genet 2007, 121:125-136.
32. Hollingworth P., Hamshere M.L., Holmans P.A., O'Donovan M.C., Sims R., Powell J., Lovestone S., Myers A., DeVrieze F.W., Hardy J., Goate A., Owen M., Williams J. Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. Am. J. Med. Genet. B Neuropsychiatr. Genet 2007, 144B:841-848.
33. Holmes C., Arranz M.J., Powell J.F., Collier D.A., Lovestone S. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum. Mol. Genet 1998, 7:1507-1509.
34. Holmes C., Levy R., McLoughlin D.M., Powell J.F., Lovestone S. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1996, 61:580-583.
35. Holmes C., Smith H., Ganderton R., Arranz M., Collier D., Powell J., Lovestone S. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J. Neurol. Neurosurg. Psychiatry 2001, 71:777-779.
36. Jones G., Zammit S., Norton N., Hamshere M.L., Jones S.J., Milham C., Sanders R.D., McCarthy G.M., Jones L.A., Cardno A.G., Gray M., Murphy K.C., Owen M.J. Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. Br. J. Psychiatry 2001, 179:351-355.
37. Jonsson E.G., Norton N., Gustavsson J.P., Oreland L., Owen M.J., Sedvall G.C. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J. Psychiatr. Res 2000, 34:239-244.
38. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 1996, 153:466-476.
39. Kim S.J., Kim Y.S., Lee H.S., Kim S.Y., Kim C.H. An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects. J. Neural Transm 2006, 113:877-886.
40. Kirchheiner J., Nickchen K., Sasse J., Bauer M., Roots I., Brockmoller J. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. Pharmacogenomics J. 2007, 7:48-55.
41. Kotler M., Barak P., Cohen H., Averbuch I.E., Grinshpoon A., Gritsenko I., Nemanov L., Ebstein R.P. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am. J. Med. Genet 1999, 88:628-633.
42. Lachman H.M., Nolan K.A., Mohr P., Saito T., Volavka J. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am. J. Psychiatry 1998, 155:835-837.
43. Lam L.C., Tang N.L., Ma S.L., Zhang W., Chiu H.F. 5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease. Int. J. Geriatr. Psychiatry 2004, 19:523-526.
44. Lee Y., Lin P.Y. Association between serotonin transporter gene polymorphism and eating disorders: A meta-analytic study. Int. J. Eat. Disord. 2009, Int J Eat Disord 2009 Aug 25.
45. Lopez L.S., Croes E.A., Sayed-Tabatabaei F.A., Claes S., Van B.C., Van Duijn C.M. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis. Biol. Psychiatry 2005, 57:999-1003.
46. Lopez-Leon S., Janssens A.C., Gonzalez-Zuloeta Ladd A.M., Del-Favero J., Claes S.J., Oostra B.A., van Duijn C.M. Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry 2008, 13:772-785.
47. Lyketsos C.G., Steinberg M., Tschanz J.T., Norton M.C., Steffens D.C., Breitner J.C. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am. J. Psychiatry 2000, 157:708-714.
48. Mast B.T. Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke. Am. J. Geriatr. Psychiatry 2004, 12:315-322.
49. Mast B.T. Impact of cognitive impairment on the phenomenology of geriatric depression. Am. J. Geriatr. Psychiatry 2005, 13:694-700.
50. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
51. Muthen l., Muthen B. Mplus User's Guide. Statistical Analysis With Latent Variables 2006, Muthen and Muthen, Los Angeles, CA. fourth ed.
52. Nacmias B., Tedde A., Forleo P., Piacentini S., Guarnieri B.M., Bartoli A., Ortenzi L., Petruzzi C., Serio A., Marcon G., Sorbi S. Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease. Biol. Psychiatry 2001, 50:472-475.
53. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Toulopoulou T., Bramon E., Walshe M., Murray R.M., Collier D.A., McGuire P. Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc. Natl. Acad. Sci. U. S. A 2009, 106:13600-13605.
54. Pritchard A.L., Harris J., Pritchard C.W., Coates J., Haque S., Holder R., Bentham P., Lendon C.L. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:123-126.
55. Pritchard A.L., Harris J., Pritchard C.W., Coates J., Haque S., Holder R., Bentham P., Lendon C.L. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease. Neurobiol. Aging 2008, 29:341-347.
56. Pritchard A.L., Pritchard C.W., Bentham P., Lendon C.L. Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable Alzheimer disease patients. Dement. Geriatr. Cogn. Disord 2007, 24:201-206.
57. Pritchard A.L., Pritchard C.W., Bentham P., Lendon C.L. Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease. Dement. Geriatr. Cogn. Disord 2008, 26:257-260.
58. Pritchard A.L., Ratcliffe L., Sorour E., Haque S., Holder R., Bentham P., Lendon C.L. Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease. Int. J. Geriatr. Psychiatry 2009, 24:1020-1025.
59. Proitsi P., Hamilton G., Tsolaki M., Lupton M., Daniilidou M., Hollingworth P., Archer N., Foy C., Stylios F., McGuinness B., Todd S., Lawlor B., Gill M., Brayne C., Rubinsztein D.C., Owen M., Williams J., Craig D., Passmore P., Lovestone S., Powell J.F. A Multiple Indicators Multiple Causes (MIMIC) Model of Behavioural and Psychological Symptoms in Dementia BPSD. Neurobiol. Aging 2009, Neurobiol Aging 2009 Apr 20.
60. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 2007, 81:559-575.
61. Rocchi A., Micheli D., Ceravolo R., Manca M.L., Tognoni G., Siciliano G., Murri L. Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. Genet. Test 2003, 7:309-314.
62. Sabol S.Z., Nelson M.L., Fisher C., Gunzerath L., Brody C.L., Hu S., Sirota L.A., Marcus S.E., Greenberg B.D., Lucas F.R., Benjamin J., Murphy D.L., Hamer D.H. A genetic association for cigarette smoking behavior. Health Psychol 1999, 18:7-13.
63. Scarmeas N., Brandt J., Albert M., Devanand D.P., Marder K., Bell K., Ciappa A., Tycko B., Stern Y. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 2002, 58:1182-1188.
64. Steele C., Rovner B., Chase G.A., Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am. J. Psychiatry 1990, 147:1049-1051.
65. Strous R.D., Bark N., Parsia S.S., Volavka J., Lachman H.M. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 1997, 69:71-77.
66. Strous R.D., Nolan K.A., Lapidus R., Diaz L., Saito T., Lachman H.M. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am. J. Med. Genet. B Neuropsychiatr. Genet 2003, 120B:29-34.
67. Sweet R.A., Devlin B., Pollock B.G., Sukonick D.L., Kastango K.B., Bacanu S.A., Chowdari K.V., DeKosky S.T., Ferrell R.E. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Mol. Psychiatry 2005, 10:1026-1036.
68. Sweet R.A., Nimgaonkar V.L., Devlin B., Lopez O.L., DeKosky S.T. Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002, 58:907-911.
69. Sweet R.A., Nimgaonkar V.L., Kamboh M.I., Lopez O.L., Zhang F., DeKosky S.T. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Arch. Neurol 1998, 55:1335-1340.
70. Sweet R.A., Pollock B.G., Sukonick D.L., Mulsant B.H., Rosen J., Klunk W.E., Kastango K.B., DeKosky S.T., Ferrell R.E. The 5-://R polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int. Psychogeriatr 2001, 13:401-409.
71. Tunstall N., Owen M.J., Williams J., Rice F., Carty S., Lillystone S., Fraser L., Kehoe P., Neill D., Rudrasingham V., Sham P., Lovestone S. Familial influence on variation in age of onset and behavioural phenotype in Alzheimer's disease. Br. J. Psychiatry 2000, 176:156-159.
72. Vandenbergh D.J., O'Connor R.J., Grant M.D., Jefferson A.L., Vogler G.P., Strasser A.A., Kozlowski L.T. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addict Biol 2007, 12:106-116.
73. Weickert T.W., Goldberg T.E., Mishara A., Apud J.A., Kolachana B.S., Egan M.F., Weinberger D.R. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol. Psychiatry 2004, 56:677-682.
74. Yacubian J., Sommer T., Schroeder K., Glascher J., Kalisch R., Leuenberger B., Braus D.F., Buchel C. Gene-gene interaction associated with neural reward sensitivity. Proc. Natl. Acad. Sci. U. S. A 2007, 104:8125-8130.